Andrew Chantry

Key Research Interests and Expertise

At present, his laboratory has a translational and drug discovery focus, and has projects aimed at developing novel therapeutic strategies targeting abnormal TGFb activity in cancer metastasis, leukaemia, osteoarthritis, and fibrotic disease. 

Current research projects; 

• Novel therapeutics targeting the WWP2 Ubiquitin Ligase oncogene in malignant melanoma Novel Regulation of TGFb signalling by a protein kinase over-expressed in Breast Cancer
• A new dual therapy approach for the treatment of chronic myeloid leukaemia
• A new approach to target abnormal chondrocyte growth in osteoarthritis and the aging joint’

PhD Positions

Click here for current PhD opportunities in Biological Sciences. But feel free to email me to discuss projects outside these areas and alternative sources of funding.